Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive

Carlota Gudiol1,2,3, Rachel S Hicklen4, Pablo C Okhyusen5

  • 1Infectious Diseases Department, Bellvitge University Hospital, IDIBIELL, University of Barcelona, Barcelona, Spain.

Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of infections as simulators of irAEs in cancer patients.

Related Concept Videos